Mirum Pharmaceuticals, Inc.
MIRM NASDAQHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Aug 5, 2026
ET
EPS Est.
-0.74
EPS Actual
-1.06
Revenue Est.
$166.3M
Revenue Actual
$176.2M
Next Earnings Report
Date
Nov 3, 2026 · Tue
Time
Your time zone matches ET
After-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
-0.53
Revenue Est.
$178.1M
Company Overview
Mirum Pharmaceuticals, Inc. (ticker MIRM) is listed on NASDAQ with a market cap of about $5.87B. Its next earnings report (FY2026 Q3) is expected on Nov 3, 2026 (ET), After-market, with consensus EPS of -0.53. In the last 15 reported quarters, EPS beat consensus estimates 6 times.
Actual EPS TrendRecently15Term · Mar 8, 2023 → Aug 5, 2026
Mar 8, 2023Range: -13.43 ~ 0.05Aug 5, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 5, 2026 | -- | -0.74 | Below forecast↓-1.06 | $166.3M | $176.2M |
| May 6, 2026 | -- | -0.40 | Below forecast↓-13.43 | $148.2M | $159.9M |
| Feb 25, 2026 | -- | 0.02 | Below forecast↓-0.11 | $142.5M | $148.9M |
| Nov 4, 2025 | -- | -0.10 | Above forecast↑0.05 | $140.9M | $133M |
| Aug 6, 2025 | -- | -0.31 | Above forecast↑-0.12 | $130.1M | $127.8M |
| May 7, 2025 | -- | -0.39 | Above forecast↑-0.30 | $98.4M | $111.6M |
| Feb 26, 2025 | -- | -0.27 | Below forecast↓-0.49 | $96.6M | $99.4M |
| Nov 12, 2024 | -- | -0.45 | Above forecast↑-0.30 | $95.4M | $90.4M |
| Aug 7, 2024 | -- | -0.48 | -0.52 | $75.3M | $77.9M |
| May 8, 2024 | -- | -0.40 | Below forecast↓-0.54 | $70.2M | $69.2M |
| Feb 28, 2024 | -- | -0.34 | Below forecast↓-0.66 | $67.8M | $69.6M |
| Nov 2, 2023 | -- | -0.64 | -0.57 | $68.3M | $47.7M |
| Aug 3, 2023 | -- | -0.81 | Below forecast↓-1.94 | $30.4M | $37.5M |
| May 4, 2023 | -- | -0.96 | Above forecast↑-0.80 | $28.7M | $31.6M |
| Mar 8, 2023 | -- | -0.98 | -0.99 | $24.6M | $27.9M |
Original Filings (SEC)
Quarterly10-Q · 2026-08-05 ↗
Earnings Release8-K · 2026-08-05 ↗
Quarterly10-Q · 2026-05-06 ↗
Earnings Release8-K · 2026-05-06 ↗
Annual10-K · 2026-02-25 ↗
Earnings Release8-K · 2026-02-25 ↗
Quarterly10-Q · 2025-11-04 ↗
Earnings Release8-K · 2025-11-04 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
